(R)-3-Hydroxybutanoate

(R)-3-Hydroxybutanoate

SCHEMBL194589

CC(O)CC(=O)[O-].[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of (R)-3-Hydroxybutanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 911 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130876-A1 ADMINISTRATION OF BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN HUMANS AXCESS GLOBAL SCIENCES LLC (US) 2026-05-14 US claimed
US-12551455-B2 Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate AXCESS GLOBAL SCIENCES, LLC (US) 2026-02-17 US claimed
US-12496283-B2 Administration of R-beta-hydroxybutyrate and related compounds in humans AXCESS GLOBAL SCIENCES, LLC (US) 2025-12-16 US claimed
US-12396974-B2 Ketone ester as a therapeutic treatment of Covid-19 and related viral infections KetoneAid (US) 2025-08-26 US claimed
EP-4595774-A1 COMPLEX OF 3-HYDROXYBUTYRIC ACID AND SODIUM 3-HYDROXYBUTYRATE AND PREPARATION METHOD THEREFOR Nanjing Nutrabuilding Bio-Tech Co., Ltd. (CN) 2025-08-06 EP claimed
US-20250221948-A1 Complex of 3-hydroxybutyric acid and sodium 3-hydroxybutyrate and preparation method thereof NANJING NUTRABUILDING BIO-TECH CO., LTD. (CN) 2025-07-10 US claimed
CN-120130645-A Extraction method and application of agaricus bisporus fermentation product 吉林农业大学 2025-06-13 CN claimed
CN-119968131-A 3-Hydroxybutyric acid and sodium 3-hydroxybutyrate compound and preparation method thereof 南京纽邦生物科技有限公司 2025-05-09 CN claimed
CN-119926968-A Method for constructing functional bacteria ecological niche in soil to degrade chlorinated hydrocarbon in soil 中铁四局集团第四工程有限公司 2025-05-06 CN claimed
WO-2025085934-A1 MITIGATING PASSIVATION OF METAL ELECTRODES FORM ENERGY, INC. (US) 2025-04-24 WO claimed
WO-2007007025-A1 CORROSION INHIBITOR OR INTENSIFIER FOR USE IN ACIDIZING TREATMENT FLUIDS HALLIBURTON ENERGY SERVICES, INC. (US) 2007-01-18 WO claimed
US-20070010404-A1 Corrosion inhibitor or intensifier for use in acidizing treatment fluids HALLIBURTON ENERGY SERVICES, INC. 2007-01-11 US claimed
US-6613356-B1 Medication for weight loss by means of appetite suppression and a method for administering this medication to humans and other mammals. The medication comprises potassium butyrate or closely related chemical compounds, together with chemicals AXCESS GLOBAL SCIENCES, LLC 2003-09-02 US claimed
US-6562872-B1 Rapidly eliminable perfluorocarbon (PFC) and a slowly eliminable perfluorinated cyclic tertiary amine, perfluoro-N-4- (methylcyclohexyl)-piperidine and additionally comprises not less then three rapidly eliminable and three Otkrytoe Aktsionernoe Obschestvo Naucho-Proizvodstven-Naya Firma “Perftoran” (RU) 2003-05-13 US claimed
EP-1306083-A1 EMULSION OF PERFLUORORGANIC COMPOUNDS FOR MEDICAL PURPOSES, METHOD FOR PRODUCING SAID EMULSION AND METHODS FOR CURING AND PREVENTING DISEASES WITH THE AID OF THE EMULSION Otkrytoe Aktsionernoe Obchestvo Nauchno-Proizvodstvennaya Firma "Perftoran" (RU) 2003-05-02 EP claimed
EP-0780123-B1 Beta-hydroxybutyric acid or acetoacetic acid or salts or esters therof for use in improving cerebral function BTG INT LTD (GB) 2002-06-12 EP claimed
EP-1188437-A2 Beta-hydroxybutyric acid or acetoacetic acid or salts or esters therof for use in improving cerebral function BTG INTERNATIONAL LIMITED (GB) 2002-03-20 EP claimed
US-6136862-A INTRAVENOUSLY ADMINISTERING AN ORGANIC ACID, ESTER, OR SALT THEREOF SHIMIZU PHARMACEUTICAL CO., LTD. (JP) 2000-10-24 US claimed
EP-0355453-A2 Use of 3-hydroxybutyric acid as an energy source KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1990-02-28 EP claimed
US-4138291-A OBTAINING BACTERIA STRAIN WHICH CAN CONVERT CARBON SOURCE INTO POLY-(D-3-HYDROXYBUTYRIC ACID) AGROFERM AG (CH) 1979-02-06 US claimed